+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Metagenomics Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • February 2024
  • Region: Global
  • Expert Market Research
  • ID: 5941131

Global Metagenomics Market Outlook

The global metagenomics market size is anticipated to grow at a CAGR of 14.2% during the forecast period of 2024-2032, driven by increasing interest in exploring the human microbiome, soil microbiome, and other environmental microbiomes across the globe.

Metagenomics: Introduction

Metagenomics is a revolutionary field that involves analyzing the collective genetic material from environmental samples, bypassing the need for isolating and cultivating individual species. This approach allows scientists to study complex microbial communities directly in their natural habitats, uncovering a vast diversity of organisms, many of which are otherwise difficult or impossible to grow in the lab. Metagenomics not only reveals how these microorganisms interact and function but also opens doors to discovering novel genes and biochemical pathways.

Key Trends in the Global Metagenomics Market

Continuous improvements in high-throughput sequencing technologies and bioinformatics tools are significantly enhancing the efficiency and accuracy of metagenomic analyses. This trend is enabling deeper insights into microbial communities and their functions.

There's an increasing interest in exploring the human microbiome, soil microbiome, and other environmental microbiomes. This trend is driven by a growing understanding of the profound impact that microorganisms have on human health, environmental health, and agricultural productivity.

The metagenomics field is becoming integral in drug discovery, development of novel enzymes, and bioremediation processes. Companies are investing in metagenomic approaches to harness the potential of microbial communities for developing new products and solutions.

There's a rising application of metagenomics in agriculture for soil health analysis, crop protection, and yield enhancement. This trend is driven by the need for sustainable agricultural practices and the desire to reduce chemical inputs.

As the field grows, there is an increasing focus on the ethical, legal, and social implications of metagenomic research. Issues related to data privacy, biosafety, and bioethical considerations are becoming more prominent.

The complexity of metagenomic data analysis is fostering collaborations between academic institutions, government agencies, and private entities. These partnerships are crucial for advancing research and translating findings into practical applications.

The demand for skilled professionals in the field of metagenomics is leading to the development of specialized training programs and courses, aiming to equip the workforce with the necessary expertise in bioinformatics and data analysis.

Global Metagenomics Market Segmentation

Market Breakup by Product and Services

  • Software
  • Kits and Reagents
  • Sequencing and Data Analytics Service

Market Breakup by Technology

  • Shotgun Sequencing
  • 16S Sequencing
  • Whole Genome Sequencing
  • Others

Market Breakup by Application

  • Environmental Application
  • Clinical Diagnostics Applications
  • Soil Microbiome Applications
  • Drug Discovery Applications
  • Biotechnology Applications
  • Food and Nutrition Applications
  • Veterinary Applications
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Metagenomics Market Overview

North America, particularly the United States, dominates in technological innovation and research funding, There's a strong emphasis on drug discovery, personalized medicine, and environmental conservation, propelling advanced metagenomic applications.

Europe market is characterized by robust research initiatives and collaborations, especially within the EU framework programs. Countries like Germany, the UK, and France focus on integrating metagenomics into healthcare, agriculture, and bioenergy sectors.Asia-Pacific is a rapidly growing market, with countries like China, Japan, and India investing heavily in biotechnology and bioinformatics. The region shows increasing interest in applying metagenomics for agricultural improvement, disease surveillance, and biodiversity studies.

Latin America growth is driven by biodiversity research and the application of metagenomics in agriculture and environmental monitoring, with countries like Brazil and Mexico taking the lead.

Middle East & Africa market is emerging, with a focus on healthcare applications and infectious disease research. Countries are increasingly investing in genomics and bioinformatics infrastructure to harness the potential of metagenomics.

Global Metagenomics Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Agilent Technologies, Inc
  • ENTEROME
  • IntegraGen
  • Oxford Nanopore Technologies
  • QIAGEN
  • Illumina, Inc
  • Pacific Biosciences of California, Inc
  • Swift Biosciences Inc.
  • Thermo Fisher Scientific Inc.
  • BGI
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • Computomics Gmbh.
  • Microsynth AG
  • Arc Bio LLC


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Metagenomics Market Overview
3.1 Global Metagenomics Market Historical Value (2017-2023)
3.2 Global Metagenomics Market Forecast Value (2027-2032)
4 Global Metagenomics Market Landscape
4.1 Global Metagenomics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Metagenomics Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Metagenomics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Metagenomics Market Segmentation
6.1 Global Metagenomics Market by Product and Services
6.1.1 Market Overview
6.1.2 Software
6.1.3 Kits and Reagents
6.1.4 Sequencing and Data Analytics Services
6.2 Global Metagenomics Market by Technology
6.2.1 Market Overview
6.2.2 Shotgun Sequencing
6.2.3 16S Sequencing
6.2.4 Whole Genome Sequencing
6.2.5 Others
6.3 Global Metagenomics Market by Application
6.3.1 Market Overview
6.3.2 Environmental Application
6.3.3 Clinical Diagnostics Applications
6.3.4 Soil Microbiome Applications
6.3.5 Drug Discovery Applications
6.3.6 Biotechnology Applications
6.3.7 Food and Nutrition Applications
6.3.8 Veterinary Applications
6.3.9 Others
6.4 Global Metagenomics Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Metagenomics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Metagenomics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Metagenomics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Metagenomics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Metagenomics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Agilent Technologies, Inc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 ENTEROME
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 IntegraGen
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Oxford Nanopore Technologies
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 QIAGEN
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Illumina, Inc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Pacific Biosciences of California, Inc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Swift Biosciences Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Thermo Fisher Scientific Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BGI
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bio-Rad Laboratories, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Promega Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Computomics Gmbh.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Microsynth AG
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Arc Bio LLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Metagenomics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Agilent Technologies Inc
  • ENTEROME
  • IntegraGen
  • Oxford Nanopore Technologies
  • QIAGEN
  • Illumina Inc Pacific Biosciences of California Inc
  • Swift Biosciences Inc. Thermo Fisher Scientific Inc.
  • BGI
  • Bio-Rad Laboratories Inc.
  • Promega Corporation
  • Computomics Gmbh.
  • Microsynth AG
  • Arc Bio LLC

Methodology

Loading
LOADING...